{"database": "lobbying", "table": "lobbying_activities", "rows": [[2470533, "071c24a6-0bcd-4729-89fa-e655d52437f3", "Q2", "TWENTY-FIRST CENTURY GROUP, INC.", 38687, "GLOBAL ALZHEIMER'S PLATFORM FOUNDATION", 2020, "second_quarter", "MED", "Inform Congress about the impact of COVID-19 on Alzheimer's clinical trials.", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 10000, null, 0, 0, "2020-07-17T09:30:16.150000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2470533"], "units": {}, "query_ms": 0.352649949491024, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}